Showing 4201-4210 of 5062 results for "".
Embracing Change: Father-Son Dermatologists Reflect on Their Decades of Experience
https://practicaldermatology.com/topics/general-topics/embracing-change-father-son-dermatologists-reflect-on-their-decades-of-experience/24023/With Kenneth Beer, MD, and Jacob I. Beer, MDBy Heidi SpleteThe Financial Contract Every Practice Must Have... And Very Few Do
https://practicaldermatology.com/topics/practice-management/the-financial-every-practice-must-have-and-very-few-do/21166/Going Digital: Marketing for the 21st Century
https://practicaldermatology.com/topics/practice-management/going-digital-marketing-for-the-21st-century/22911/Efficient analysis and use of practice data will generate much larger returns on investment for aesthetic and medical practices.DermWireTV: Sotyktu Approval, Cetaphil at 75, Psoriasis/Depression Link
https://practicaldermatology.com/topics/psoriasis/dermwiretv-sotyktu-approval-cetaphil-at-75-psoriasisdepression-link/20138/FDA has approved Bristol Myers Squibb’s Sotyktu (deucravacitinib) for the oral treatment of adults with moderate-to-severe plaque psoriasis who are candidates for systemic therapy or phototherapy. April Armstrong, MD discusses the first TYK-2 inhibitor approved for psoriasis. As Cetaphil (Galderma)Practical Dermatology Roundtable: The Role of Adjuvant Skin Cleansing and Moisturizing in Treating Psoriasis and Other Inflammatory Diseases, Ch. 5
https://practicaldermatology.com/programs/the-practical-dermatology-roundtable/practical-dermatology-roundtable-the-role-of-adjuvant-skin-cleansing-and-moisturizing-in-treating-psoriasis-and-other-inflammatory-diseases-ch-5/56873/In the fifth installment of this eight-part series, host Ted Lain, MD, MBA, FAAD, and guests Zoe Diana Draelos, MD, and Firas George Hougeir, MD, FAAD, explore how these findings may generalize to other inflammatory skin conditions and reviews the unique properties of the skincare products used in tDermWireTV: Meet Crown Aesthetics, Revance to Market Teoxane Fillers, Almirall Collaborates
https://practicaldermatology.com/videos/dermwire-tv/dermwiretv-meet-crown-aesthetics-revance-to-market-teoxane-fillers-almirall-collaborates/19719/On the heels of recent acquisitions, Crown Laboratories is reorganizing and rebranding as three divisions: Crown Aesthetics, Crown Beauty, and Crown Therapeutics. Revance gains immediate and exclusive rights to commercialize Teoxane’s RHA 2, RHA 3, and RHA 4 products, which include lidocaine.Treatment Considerations in the Short- and Long-Term Management of Plaque Psoriasis: Is There A Role for Tazarotene?
https://practicaldermatology.com/topics/psoriasis/treatment-considerations-in-the-shortandlong-term-management-of-plaquepsoriasis-is-there-a-role-for-tazarotene/23041/Tazarotene is almost a forgotten entity in management of psoriasis, despite quality data showing it can be both tolerable and effective—when used appropriately.“Natural” Remedies for Eczema: Evidence for the Alternative?
https://practicaldermatology.com/topics/general-topics/natural-remedies-for-eczema-evidence-for-the-alternative/22936/Limited data suggest the possibility that some natural agents may be particularly useful in the treatment of atopic dermatitis.One Doctor’s Legal Education Odyssey
https://practicaldermatology.com/topics/practice-management/one-doctors-legal-education-odyssey/23999/What happens when a seasoned dermatologist and dermatopathologist pursues his childhood dream of becoming a lawyer?Recent Developments
https://practicaldermatology.com/columns/recent-developments/recent-developments-26/23564/